Latest Alzheimer's News
A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat or cure Alzheimer's disease and other serious conditions, the U.S. Food and Drug Administration says.
The agency said it posted 12 warning letters and five online advisory letters to U.S. and foreign companies illegally selling more than 58 products, many of which are marketed as dietary supplements.
The products -- which include tablets, capsules and oils and are often sold on websites and social media -- have not been reviewed by the FDA and may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment, according to the FDA
The companies have 15 days to respond to the FDA and outline how they intend to correct the violations. Product seizures and/or injunctions are among the actions the FDA could take if the violations are not corrected.
"Science and evidence are the cornerstone of the FDA's review process and are imperative to demonstrating medical benefit, especially when a product is marketed to treat serious and complex diseases like Alzheimer's," FDA Commissioner Dr. Scott Gottlieb said in an agency news release.
"Alzheimer's is a challenging disease that, unfortunately, has no cure. Any products making unproven drug claims could mislead consumers to believe that such therapies exist and keep them from accessing therapies that are known to help support the symptoms of the disease, or worse as some fraudulent treatments can cause serious or even fatal injuries. Simply put, health fraud scams prey on vulnerable populations, waste money and often delay proper medical care -- and we will continue to take action to protect patients and caregivers from misleading, unproven products," Gottlieb said.
In the past five years, the FDA has issued more than 40 warning letters to companies illegally marketing over 80 products making Alzheimer's disease claims.
Copyright © 2018 HealthDay. All rights reserved.